Transcatheter structural heart therapies stand to replace their open-heart counterparts thanks to technological innovations and expanded patient access.
Improved functionality across four valve sizes and lowest delivery profile on market, Evolut PRO+ TAVR System launches in U.S. as TAVR patient population grows.
Includes pediatric mechanical heart valve and first minimally invasive device to treat premature babies and newborns born with an opening in their heart.